Author

Anna patjane

National Health Laboratory Service

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex SigaliD· 1 shared Antonella FolgoriiD· 1 shared Ashleigh Welsh· 1 shared Glenda GrayiD· 1 shared Lee FairlieiD· 1 shared Linda‐Gail BekkeriD· 1 shared Michela Gentile· 1 shared Nigel GarrettiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alex SigalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low seroprevalence of neutralizing antibodies to gorilla adenovirus 32 (GRAd32) in southern African populations supports evaluation of this vector platform for HIV vaccine development

Nonhlanhla N. Mkhize, Anna patjane, Nomcebo Shusha, Ashleigh Welsh, Tandile Hermanus, Prudence Kgagudi, Thopisang P. Motlou, Linda‐Gail Bekker, Glenda Gray, Nigel Garrett, Lee Fairlie, Alex Sigal, Wendy A. Burgers, Takudzwa Mangwaku, Tariro Makadzange, , Penny L. Moore

This study finds low neutralizing antibody prevalence to GRAd32 in southern African populations, suggesting its potential as an HIV vaccine vector despite prior Ad26 vaccination.

bioRxiv · May 26, 2026 · PreprintImmunology